Quick Takeaways
- HPWH TH AG filed SCHEDULE 13G/A for ADC Therapeutics SA Common Shares, par value CHF 0.08 per share (ADCT).
- Disclosed ownership: 9.6%.
- Date of event: 15 May 2025.
HPWH TH AG - 15 May 2025 SCHEDULE 13G/A Report for ADC Therapeutics SA Common Shares, par value CHF 0.08 per share (ADCT)
- Filing Manager
- HPWH TH AG
- Reporting Manager
- Dr. Hans-Peter Wild
- Symbol
- ADCT
- Shares outstanding
- 101,862,060 shares
- Disclosed Ownership
- 9,788,944 shares
- Ownership
- 9.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 19 May 2025, 19:40:24 UTC
- Date of event
- 15 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"HPWH TH AG disclosed 9.6% ownership in ADC Therapeutics SA Common Shares, par value CHF 0.08 per share (ADCT) on 15 May 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 19 May 2025, 19:40.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| HPWH TH AG | 8.5% | 8,670,588 | 8,670,588 | 0 | /s/ Dr. Hans-Peter Wild | Dr. Hans-Peter Wild/Chairman | |
| Dr. Hans-Peter Wild | 9.6% | 9,788,944 | 9,788,944 | 0 | /s/ Dr. Hans-Peter Wild | Dr. Hans-Peter Wild | |
| Thomas Pfisterer | 0.17% | 173,899 | 173,899 | 0 | /s/ Thomas Pfisterer | Thomas Pfisterer |